Opportunities for future biological therapy in SLE

Bailliere's Clinical Rheumatology

Volumn 12, Issue 3, 1998, Pages 529-541

  Wofsy, D ^a   Daikh, D I ^a  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Interleukin 10; Interleukin 6; Murine lupus; T cell co stimulation; Tumour necrosis factor

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CYTOKINE; HLA ANTIGEN CLASS 2; INTERLEUKIN 10; INTERLEUKIN 6; MEMBRANE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOIMMUNITY; CELL INTERACTION; CLINICAL TRIAL; META ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0031737320     PISSN: 09503579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3579(98)80034-4     Document Type: Article

References (51)

1. Allen RC Armitage RJ Conley ME CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome Science 259 1993 990 996
2. Aruffo A Farrington M Hollenbaugh D The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome Cell 72 1993 291 300
3. Bluestone JA New perspectives of CD28-B7-mediated T cell costimulation Immunity 2 1995 555 559
4. 2 fragments of monoclonal antibody to L3T4: suppression of autoimmunity does not depend on T helper cell depletion Journal of Immunology 142 1989 1470 1475
5. Christadoss P Dauphinee ML Immunotherapy for myasthenia gravis: a murine model Journal of Immunology 136 1986 2437 2440
6. Connolly K Roubinian JR Wofsy D Development of murine lupus in CD4-depleted NZB/NZW mice: sustained inhibition of residual CD4+ T cells is required to suppress autoimmunity Journal of Immunology 149 1992 3083 3088
7. Daikh DI Finck BK Linsley PS Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways Journal of Immunology 159 1997 3104 3108
8. Durie FH Fava RA Foy TM Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40 Science 261 1993 1328 1330
9. Durie FH Foy TM Masters SR The role of CD40 in the regulation of humoral and cell-mediated immunity Immunology Today 15 1994 406 411
10. Early GS Zhao W Burns CM Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand Black × New Zealand White mice Journal of Immunology 157 1996 3159 3164
11. Elliot MJ Maini RN Feldmann M Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis Lancet 344 1994 1105 1110
12. 1 mice Journal of Clinical Investigation 94 1994 585 591
13. Finck BK Linsley PS Wofsy D Treatment of murine lupus with CTLA4Ig Science 265 1994 1225 1227
14. Gimmi CD Freeman GJ Gribben GJ B cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2 Proceedings of the National Academy of Sciences of the USA 88 1991 6575 6579
15. Goeddel DV Aggarwal BB Gray PW Tumor necrosis factor: gene structure and biological activities Cold Spring Harbor Symposia on Quantitative Biology 51 1986 597 609
16. 1 mice Clinical Immunology and Immunopathology 52 1989 421 434
17. Gordon C Richards N Howie AJ Urinary IL-6: a marker for mesangial proliferative glomerulonephritis? Clinical and Experimental Immunology 86 1991 145 149
18. Griggs ND Agersborg SS Noelle RJ The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expression and pathogenic acquisition of self reactive T cells Journal of Experimental Medicine 183 1996 801 810
19. Harding FA McArthur JG Gross JA CD28-mediated signaling co-stimulates murine T cells and prevents induction of anergy in T cell clones Nature 356 1992 607 610
20. Herzog CH Walker CH Muller W Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells Journal of Autoimmunity 2 1989 627 642
21. Hiepe F Volk HD Apostoloff E Treatment of severe systemic lupus erythematosus with anti-CD4 monoclonal antibody Lancet 338 1991 1529 1530
22. Hirohata S Miyamoto T Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement Arthritis and Rheumatism 33 1990 644 649
23. Horii Y Iwano W Hirata E Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis Kidney International 39 1993 S71 S75
24. 1 mice Journal of Experimental Medicine 179 1994 305 310
25. Jacob CO McDevitt HO Tumor necrosis factor-α in murine autoimmune ‘lupus’ nephritis Nature 331 1988 356 358
26. Jacob CO McDevitt HO Interferon gamma and tumor necrosis factor in autoimmune disease models: implications for immunoregulation and genetic susceptibility Talal N Molecular Autoimmunity 1991 Academic Press San Diego 107 126
27. Kalechman Y Gafter U Da JP Delay in the onset of systemic lupus erythematosus following treatment with the immunomodulator AS101 Journal of Immunology 159 1997 2658 2667
28. Kitani A Hara M Hirose T Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression Clinical and Experimental Immunology 88 1992 75 83
29. Koike T Itoh Y Ishi T Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice Diabetes 36 1987 539 541
30. Levy R Weisman M Wiesenhutter C Results of a placebo-controlled, multicenter trial using a primatized non-depleting, anti-CD4 monoclonal antibody in the treatment of rheumatoid arthritis Arthritis and Rheumatism 39 1996 S122
31. Linker-Israeli M Deans RJ Wallace DJ Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis Journal of Immunology 147 1991 117 123
32. Linsley PS Brady W Urnes M CTLA-4 is a second receptor for the B cell activation antigen B7 Journal of Experimental Medicine 174 1991 561 569
33. Linsley PS Wallace PM Johnson J Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule Science 257 1992 792 795
34. Llorente L Richaud-Patin Y Wijdenes J Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus European Cytokine Network 4 1993 421 430
35. Llorente L Zou W Levy Y Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus Journal of Experimental Medicine 181 1995 839 844
36. van der Lubbe PA Dijkmans BA Markusse HM A randomized, double-blind, placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis Arthritis and Rheumatism 38 1995 1097 1106
37. Marrack P Kappler JW How the immune system recognizes the body Scientific American 269 1993 80 89
38. Mohan C Shi Y Laman JD Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis Journal of Immunology 154 1995 1470 1480
39. Moore KW O'Garra A de Waal Malefyt R Interleukin 10 Annual Review of Immunology 11 1993 165 190
40. Moreland LW Bucy RP Tilden A Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis Arthritis and Rheumatism 36 1993 307 318
41. Moreland LW Pratt PW Bucy RP Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody: long-term followup of CD4+ T cell counts Arthritis and Rheumatism 37 1994 834 838
42. Moreland LW Baumgartner SW Schiff MH Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein New England Journal of Medicine 337 1997 141 147
43. Ranges GE Sriram S Cooper SM Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4 Journal of Experimental Medicine 162 1985 1105 1110
44. Santoro TJ Portanova JP Kotzin BL The contribution of L3T4+ T cells to lympho-proliferation and autoantibody production in MRL- lpr/lpr mice Journal of Experimental Medicine 167 1988 1713 1718
45. Van Snick J Interleukin 6: an overview Annual Review of Immunology 8 1990 253 278
46. Steinberg AD Raveche ES Laskin CA Systemic lupus erythematosus: insights from animal models Annals of Internal Medicine 100 1984 714 727
47. Tan P Anasetti C Hansen JA Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1 Journal of Experimental Medicine 177 1993 165 173
48. Waldor MK Sriram S Hardy R Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker Science 227 1985 415 417
49. Wofsy D Administration of monoclonal anti-T cell antibodies retards murine lupus in BXSB mice Journal of Immunology 136 1986 4554 4560
50. 1 mice with monoclonal antibody to L3T4 Journal of Experimental Medicine 161 1985 378 391
51. Wofsy D Seaman WE Reversal of advanced murine lupus in NZB/NZW mice by treatment with monoclonal antibody to L3T4 Journal of Immunology 138 1987 3247 3253